These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1429 related items for PubMed ID: 17016620

  • 1. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM, Korja S, Venhoranta H, Hakkarainen T, Pirinen E, Heikkinen S, Pellinen R, Mäkinen K, Wahlfors J.
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [Abstract] [Full Text] [Related]

  • 2. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM, Tenhunen A, Pasanen T, Meriläinen O, Pellinen R, Mäkinen K, Alhava E, Wahlfors J.
    Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
    [Abstract] [Full Text] [Related]

  • 3. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
    Wang YP, Tang XJ, Zhou QH, Che GW, Chen XH, Zhu DX.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
    [Abstract] [Full Text] [Related]

  • 4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 5. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
    Mathis JM, Williams BJ, Sibley DA, Carroll JL, Li J, Odaka Y, Barlow S, Nathan CO, Li BD, DeBenedetti A.
    J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401
    [Abstract] [Full Text] [Related]

  • 6. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [Abstract] [Full Text] [Related]

  • 7. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
    Tang XJ, Wang YP, Zhou QH, Che GW, Chen XH, Zhu DX.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
    Petrigliano FA, Virk MS, Liu N, Sugiyama O, Yu D, Lieberman JR.
    Prostate; 2009 Sep 15; 69(13):1422-34. PubMed ID: 19489029
    [Abstract] [Full Text] [Related]

  • 10. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
    Pellinen R, Hakkarainen T, Wahlfors T, Tulimäki K, Ketola A, Tenhunen A, Salonen T, Wahlfors J.
    Int J Oncol; 2004 Dec 15; 25(6):1753-62. PubMed ID: 15547714
    [Abstract] [Full Text] [Related]

  • 11. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW.
    Cancer Gene Ther; 2004 Feb 15; 11(2):148-55. PubMed ID: 14695756
    [Abstract] [Full Text] [Related]

  • 12. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
    Yan C, Wen-Chao L, Hong-Yan Q, Rui Z, Wei-Lin J, Hua H.
    Acta Oncol; 2007 Feb 15; 46(6):773-81. PubMed ID: 17653900
    [Abstract] [Full Text] [Related]

  • 13. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
    Kong BH, Song Y, Ma DX, Qu X, Jiang S.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun 15; 39(6):390-5. PubMed ID: 15312323
    [Abstract] [Full Text] [Related]

  • 14. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
    Kurdow R, Schniewind B, Boehle AS, Haye S, Boenicke L, Dohrmann P, Kalthoff H.
    Anticancer Res; 2004 Jun 15; 24(2B):827-31. PubMed ID: 15161034
    [Abstract] [Full Text] [Related]

  • 15. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S, Shimura S, Nasu Y, Kaku H, Kumon H, Yang G, Wang J, Timme TL, Aguilar-Cordova E, Thompson TC.
    Prostate Cancer Prostatic Dis; 2002 Jun 15; 5(4):316-25. PubMed ID: 12627218
    [Abstract] [Full Text] [Related]

  • 16. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS, Hughes DE, Lichtsteiner SP, Wang Z, Lebkowski JS, Vasserot AP.
    Gene Ther; 2001 Apr 15; 8(7):568-78. PubMed ID: 11319624
    [Abstract] [Full Text] [Related]

  • 17. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
    Konson A, Ben-Kasus T, Mahajna JA, Danon A, Rimon G, Agbaria R.
    Cancer Gene Ther; 2004 Dec 15; 11(12):830-40. PubMed ID: 15359292
    [Abstract] [Full Text] [Related]

  • 18. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
    Shimura H, Suzuki H, Miyazaki A, Furuya F, Ohta K, Haraguchi K, Endo T, Onaya T.
    Cancer Res; 2001 May 01; 61(9):3640-6. PubMed ID: 11325833
    [Abstract] [Full Text] [Related]

  • 19. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
    Isomoto H, Ohtsuru A, Braiden V, Iwamatsu M, Miki F, Kawashita Y, Mizuta Y, Kaneda Y, Kohno S, Yamashita S.
    Oncol Rep; 2006 Mar 01; 15(3):629-35. PubMed ID: 16465423
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
    Kong B, Wang W, Liu C, Song L, Ma D, Qu X, Jiang J, Yang X, Zhang Y, Wang B, Wei MQ, Yang Q.
    In Vivo; 2003 Mar 01; 17(2):153-6. PubMed ID: 12792977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.